MO
Molecular Partners
MOLN.SW·SIXZurich CHFounded 2004150 employees
Micro CapbiotechPublicOncologyInfectious Disease
Platform: DARPin
Market Cap
$0.2B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
2
Stock Price & Catalysts (MOLN.SW)
Loading MOLN.SW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MOL-8666 | MOL-8666 | Approved | 4 | WEE1 | PVRB | ||
| Capirapivir | MOL-7803 | Approved | 1 | VEGF | ALSCervical Ca |
SEC Filings & Financial Documents
SEC filings are not available for SIX-listed companies.
Molecular Partners trades on SIX (CH). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)